| Financial Year |
March 31 2023 |
| Monetary Funds |
217,867,518.68 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,726,235.50 |
| Accounts Receivable |
718,693,371.39 |
| Advances to Suppliers |
9,901,073.94 |
| Other Receivables |
30,079,537.05 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
34,624,666.27 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,192,304.97 |
| Total Current Assets |
1,306,564,124.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
50,000,177.53 |
| Fixed Assetes |
103,344,662.09 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
37,375,960.90 |
| R&D expenses |
-- |
| Goodwill |
118,730,391.14 |
| Long-Term Deferred and Prepaid Expenses |
14,723,781.04 |
| Deferred Income Tax Assets |
64,518,378.87 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
412,090,732.87 |
| Total Assets |
1,718,654,857.70 |
| Short-Term Loans |
43,035,334.31 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
385,572,503.93 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
25,282,702.50 |
| Taxes Payable |
13,567,101.67 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
45,250,914.77 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,449,610.41 |
| Other Current Liabilities |
59,415,518.69 |
| Sub-Total of Current Liabilities |
644,230,585.25 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,522,958.21 |
| Deferred Income Tax Liabilities |
3,224,590.67 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
18,549,691.04 |
| Total Liabilities |
662,780,276.29 |
| Paid-In Capital(Or Share Stock) |
200,517,800.00 |
| Capital Surplus |
178,398,581.34 |
| Surplus Reserve |
26,997,818.52 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
528,402,019.12 |
| Minority Stockholder's Interest |
113,477,594.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
942,396,986.49 |
| Owner's Equity（Stockholder's Equity） |
1,055,874,581.41 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,718,654,857.70 |
